Dr. Lal Path Labs Ltd.

Healthcare · Healthcare Services

NSE: LALPATHLAB BSE: 539524

₹1971.30

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #7 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Apollo Hospitals Enterprise Limited	114,812	73.1	20.1%	4.2%	—	73	0	27
Max Healthcare Institute Limited	89,246	124.3	13.4%	-19.5%	0.22%	77	0	26
Fortis Healthcare Limited	57,664	255.5	10.5%	-27.5%	0.13%	49	26	6
Global Health Limited	35,830	74.4	13.9%	-2.5%	0.04%	74	0	30
Aster DM Quality Care Limited	35,828	205.8	8.8%	2.8%	0.43%	53	0	26
Narayana Hrudayalaya Ltd.	35,199	61.9	17.8%	-3.7%	0.26%	66	0	29
Dr. Lal Path Labs Ltd. (this stock)	33,046	38.4	20.1%	-38.0%	0.99%	82	0	88
Krishna Institute of Medical Sciences Limited	29,629	105.1	9.5%	-2.3%	—	47	0	29

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹32,812 Cr

EV / EBITDA

35.1x

EV / Sales

11.80x

Market cap / Sales

11.89x

Earnings yield

2.61%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 794 Cr, up 19.1% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 166 Cr, up 28.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	764	222	166	₹9.9400
March 31, 2026	675	170	141	₹8.4500
Dec. 31, 2025	632	123	92	₹
Sept. 30, 2025	700	195	146	₹17.4600
June 30, 2025	641	172	129	₹15.5100
March 31, 2025	577	145	148	₹17.8000
Dec. 31, 2024	528	151	114	₹
Sept. 30, 2024	584	183	135	₹16.2400
June 30, 2024	534	161	123	₹14.7600
March 31, 2024	479	120	90	₹10.7300
Dec. 31, 2023	476	120	88	₹10.7800
Sept. 30, 2023	532	151	113	₹13.6000
June 30, 2023	480	125	94	₹11.2800

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Total income (before exceptional items)	794	712	722	667	602	606	563	495	491	546	495	443	437
Operating revenue	764	675	700	641	577	584	534	479	476	532	480	431	428
Other income	30	37	23	26	25	22	29	16	15	14	15	12	9
Operating expenses	526	494	484	457	418	399	379	349	346	369	344	315	324
Operating profit	238	182	215	183	159	184	156	130	130	163	136	116	104
Operating profit margin	31.2%	26.9%	30.7%	28.6%	27.6%	31.6%	29.1%	27.2%	27.3%	30.7%	28.3%	26.8%	24.4%
Depreciation	40	43	38	33	35	18	18	20	19	19	18	21	21
Interest	6	6	5	4	5	5	6	6	6	7	7	8	8
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	222	170	195	172	145	183	161	120	120	151	125	98	84
Tax	56	29	49	43	-4	48	38	31	31	38	32	27	22
Net profit	166	141	146	129	—	135	123	90	88	113	94	71	62
EPS	9.94	8.45	17.46	15.51	17.80	16.24	14.76	10.73	10.78	13.60	11.28	8.61	7.53
Net profit (TTM)	582	—	—	—	—	436	414	384	366	340	306	292	286
EPS (TTM)	51.36	59.22	67.01	64.31	59.53	52.51	49.87	46.39	44.27	41.02	36.92	35.25	34.52

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	2,648	660	508
March 31, 2025	2,352	621	497
March 31, 2024	1,967	516	384
March 31, 2023	1,769	391	292

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	—	—	—	—	2,027^†	1,816^†	1,926^†	1,542^†	1,331^†	1,211^†	1,056^†	908^†
Operating revenue	14.4%	12.2%	2,648	2,352	1,967	1,769	1,873^†	1,490^†	1,274^†	1,165^†	1,024^†	882^†
Other income	—	—	—	—	60^†	47^†	53^†	51^†	58^†	46^†	32^†	26^†
Operating expenses	—	—	—	—	1,408^†	1,306^†	1,362^†	1,083^†	946^†	882^†	768^†	—
Operating profit	—	—	—	—	559^†	463^†	510^†	407^†	328^†	282^†	256^†	—
Operating profit margin	—	—	—	—	28.4%^†	26.2%^†	27.2%^†	27.3%^†	25.7%^†	24.3%^†	25.0%^†	—
Depreciation	—	—	—	—	76^†	82^†	75^†	70^†	68^†	36^†	31^†	32^†
Interest	—	—	—	—	27^†	34^†	28^†	15^†	15^†	1^†	1^†	—
Exceptional items, gain / (loss)	—	—	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	19.1%	12.0%	660	621	516	391	459^†	374^†	303^†	292^†	255^†	223^†
Tax	—	—	—	—	132^†	98^†	115^†	94^†	80^†	97^†	87^†	76^†
Net profit	20.2%	12.7%	508	497	384	292	344^†	280^†	223^†	195^†	168^†	147^†
EPS	—	—	—	—	46.39^†	35.25^†	41.63^†	33.93^†	27.08^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	—	—	28.4%^†	26.2%^†	27.2%^†	27.3%^†	25.7%^†	24.3%^†	25.0%^†	—
EBIT margin	—	—	27.6%^†	24.0%^†	26.1%^†	26.1%^†	24.9%^†	25.1%^†	25.0%^†	—
PBT margin	24.9%	26.4%	26.2%	22.1%	24.5%^†	25.1%^†	23.8%^†	25.1%^†	24.9%^†	25.3%^†
Net margin	19.2%	21.1%	19.5%	16.5%	18.4%^†	18.8%^†	17.5%^†	16.8%^†	16.4%^†	16.7%^†
Interest coverage	—	—	20.25x^†	12.36x^†	17.12x^†	26.28x^†	21.59x^†	418.29x^†	320.13x^†	—
Dividend payout	—	—	38.8%^†	34.0%^†	33.6%^†	35.4%^†	57.2%^†	—	—	—
Earnings retention	—	—	61.2%^†	66.0%^†	66.4%^†	64.6%^†	42.8%^†	—	—	—
Current ratio	3.44x	3.29x	—	—	—	—	—	—	—	—
Quick ratio	3.35x	3.20x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	20.6%	23.3%	—	—	—	—	—	—	—	—
Return on assets	16.7%	19.0%	—	—	—	—	—	—	—	—
Return on capital employed	—	—	—	—	—	—	—	—	—	—
Asset turnover	0.87x	0.90x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	606	-382	-256	164	442
March 31, 2025	540	-293	-325	43	497
March 31, 2024	478	32	-404	45	433
March 31, 2023	428	-289	-270	32	396
March 31, 2022	424	-448	142	63	361

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	3,049	2,473	2,305	0	0	1,495	434	234	469	41
March 31, 2025	2,621	2,134	2,051	0	0	1,277	388	267	321	32
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.